tiprankstipranks
Trending News
More News >
Tissue Regenix (GB:TRX)
:TRX
Advertisement

Tissue Regenix (TRX) Price & Analysis

Compare
14 Followers

TRX Stock Chart & Stats


Financials

Options Prices

Currently, No data available
---

Ownership Overview

0.77%99.23%
Mutual Funds
― Other Institutional Investors
99.23% Public Companies and
Individual Investors

TRX FAQ

What was Tissue Regenix’s price range in the past 12 months?
Tissue Regenix lowest share price was 25.00p and its highest was 67.00p in the past 12 months.
    What is Tissue Regenix’s market cap?
    Tissue Regenix’s market cap is £26.36M.
      When is Tissue Regenix’s upcoming earnings report date?
      Tissue Regenix’s upcoming earnings report date is Sep 03, 2025 which is in 35 days.
        How were Tissue Regenix’s earnings last quarter?
        Tissue Regenix released its earnings results on Jun 25, 2025. The company reported -0.005p earnings per share for the quarter, missing the consensus estimate of 0p by -0.005p.
          Is Tissue Regenix overvalued?
          According to Wall Street analysts Tissue Regenix’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
            Does Tissue Regenix pay dividends?
            Tissue Regenix does not currently pay dividends.
            What is Tissue Regenix’s EPS estimate?
            Tissue Regenix’s EPS estimate for its next earnings report is not yet available.
            How many shares outstanding does Tissue Regenix have?
            Tissue Regenix has 71,395,640 shares outstanding.
              What happened to Tissue Regenix’s price movement after its last earnings report?
              Tissue Regenix reported an EPS of -0.005p in its last earnings report, missing expectations of 0p. Following the earnings report the stock price went up 1.639%.
                Which hedge fund is a major shareholder of Tissue Regenix?
                Currently, no hedge funds are holding shares in GB:TRX

                Tissue Regenix Stock Smart Score

                2
                Underperform
                1
                2
                3
                4
                5
                6
                7
                8
                9
                10

                Technicals

                SMA
                Negative
                20 days / 200 days
                Momentum
                -45.98%
                12-Months-Change

                Fundamentals

                Return on Equity
                -2.91%
                Trailing 12-Months
                Asset Growth
                6.74%
                Trailing 12-Months

                Company Description

                Tissue Regenix

                Tissue Regenix (TRX) is a pioneering medical technology company that operates in the field of regenerative medicine. The company focuses on the development and commercialization of advanced tissue-based solutions, utilizing its proprietary decellularization technology. Tissue Regenix provides innovative products for wound care, orthopedic, and dental applications, helping to improve patient outcomes and quality of life.
                Similar Stocks
                Company
                Price & Change
                Follow
                Oxford BioDynamics
                Sareum Holdings
                Arecor Therapeutics PLC
                Popular Stocks
                What am I Missing?
                Make informed decisions based on Top Analysts' activity
                Know what industry insiders are buying
                Get actionable alerts from top Wall Street Analysts
                Find out before anyone else which stock is going to shoot up
                Get powerful stock screeners & detailed portfolio analysis